Bullish option flow detected in Teva with 5,108 calls trading, 3x expected, and implied vol increasing over 5 points to 44.17%. 4/14 weekly 9.5 calls and May-23 11 calls are the most active options, with total volume in those strikes near 4,000 contracts. The Put/Call Ratio is 0.09. Earnings are expected on May 2nd.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on TEVA:
- Teva’s CP trial failure may add some risk for Neurocrine, says RBC Capital
- Teva and NATCO Pharma launch additional strengths for generic Revlimid
- Teva call volume above normal and directionally bullish
- Teva announces print publication of IMPACT-TD Scale
- Teva announces FDA approval of AUSTEDO XR tablets